Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

More articles from Articles

  • Open Access
    Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders
    MARIA PAGONI, VASILEIOS L. ZOGOPOULOS, STAVROS KONTOGIANNIS, ANNIA TSOLAKOU, VASSILIOS ZOUMPOURLIS, GEORGE TH. TSANGARIS, ELEFTHERIOS FOKAEFS, IOANNIS MICHALOPOULOS, ARISTIDIS M. TSATSAKIS and NIKOLAOS DRAKOULIS
    Cancer Genomics & Proteomics March 2025, 22 (2) 285-305; DOI: https://doi.org/10.21873/cgp.20502
  • Open Access
    Engineered Methioninase-expressing Tumor-targeting Salmonella typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine
    YUTARO KUBOTA, MING ZHAO, QINGHONG HAN, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, SEI MORINAGA, KOHEI MIZUTA, MOTOKAZU SATO, MICHAEL BOUVET, KOICHI KUBOTA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics March 2025, 22 (2) 247-257; DOI: https://doi.org/10.21873/cgp.20499
  • Open Access
    DEFA1, Primarily Expressed at the Invasive Tumor Front, Promotes OSCC Cell Invasion and Tumor Growth
    HOJIN JEONG, SANG WOONG PARK and YOUNG SUN HWANG
    Cancer Genomics & Proteomics March 2025, 22 (2) 326-345; DOI: https://doi.org/10.21873/cgp.20504
  • Open Access
    Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer
    NIAMH S. O’NEILL, MARIAM RIZK, AMBER X. LI, TRACEY A. MARTIN, WEN G. JIANG and KEFAH MOKBEL
    Cancer Genomics & Proteomics March 2025, 22 (2) 231-246; DOI: https://doi.org/10.21873/cgp.20498
  • Open Access
    Accumulating Genetic Mutations from Primary to Secondary Biliary Tract Cancers: Analysis of Four Patients With Metachronous Biliary Tract Cancer Using Comprehensive Genomic Profiling
    TOSHIO KOKURYO, YOSHIO KOIKE, JUNPEI YAMAGUCHI, MASAKI SUNAGAWA, TAISUKE BABA, NOBUYUKI WATANABE, SHUNSUKE ONOE, TAKASHI MIZUNO and TOMOKI EBATA
    Cancer Genomics & Proteomics March 2025, 22 (2) 346-353; DOI: https://doi.org/10.21873/cgp.20505
  • Open Access
    SPOCD1 Enhances Cancer Cell Activities and Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma
    TUVSHIN BAYASGALAN, MITSURO KANDA, YUSUKE SATO, HAOTE ZHU, MOHAMMAD HUSSAIN HAMRAH, FLOR ESTHER GARZA MARTINEZ, TAKAHIRO SHINOZUKA, YUKI ITO, MASAHIRO SASAHARA, DAI SHIMIZU, SHINICHI UMEDA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA and YASUHIRO KODERA
    Cancer Genomics & Proteomics March 2025, 22 (2) 306-325; DOI: https://doi.org/10.21873/cgp.20503
  • Open Access
    Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women
    SYLVIA DASI, TAMMEY J. NAAB, BERNARD KWABI-ADDO, VICTOR APPREY, DESTA BEYENE, ROBERT L. DEWITTY, STEVEN NAGEL, ROBIN WILLIAMS, KELLY BOLDEN, ANDREA HAYES-DIXON, BABAK SHOKRANI, DELISHA A. STEWART, OLAKUNLE O. KASSIM, ROBERT L. COPELAND and YASMINE M. KANAAN
    Cancer Genomics & Proteomics March 2025, 22 (2) 208-230; DOI: https://doi.org/10.21873/cgp.20497
  • Open Access
    Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk
    CHIH-CHIANG HUNG, YUN-CHI WANG, HOU-YU SHIH, CHIA-HUA LIU, JIE-LONG HE, JAW-CHYUN CHEN, WEN-SHIN CHANG, CHEN-HSIEN SU, DA-TIAN BAU and CHIA-WEN TSAI
    Cancer Genomics & Proteomics March 2025, 22 (2) 258-270; DOI: https://doi.org/10.21873/cgp.20500
  • Open Access
    Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing
    YOSUKE SAITO, YUKI HOSHI, MASAMICHI SATO, MANABU SEINO, NORIKAZU WATANABE, MASAAKI KAWAI and SHUHEI SUZUKI
    Cancer Genomics & Proteomics March 2025, 22 (2) 354-362; DOI: https://doi.org/10.21873/cgp.20506
  • Open Access
    Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression
    HEE YUN, GWAN HEE HAN, DANIEL J. WEE, DOO-BYUNG CHAY, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics March 2025, 22 (2) 271-284; DOI: https://doi.org/10.21873/cgp.20501

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 2454
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire